Section Arrow
Quote
CNTX.NASDAQ
- Context Therapeutics Inc.
(Financial Status)
Quotes are at least 15-min delayed:2025/07/16 16:23 EDT
After Hours
Last
 0.849
+0.0238 (+2.88%)
Bid
0.8252
Ask
0.849
High 0.849 
Low 0.849 
Volume 1 
Regular Hours
Last
 0.8252
+0.0899 (+12.23%)
Day High 
0.8499 
Prev. Close
0.7353 
1-M High
0.8096 
Volume 
344.46K 
Bid
0.8252
Ask
0.849
Day Low
0.76 
Open
0.7652 
1-M Low
0.56 
Market Cap 
65.96M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.66 
20-SMA 0.64 
50-SMA 0.67 
52-W High 2.75 
52-W Low 0.49 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.28/-0.37
Enterprise Value
66.07M
Balance Sheet
Book Value Per Share
1.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
APMAptorum Group Limited1.94+0.9702+100.04%2.77PE
After Hours 2.03 +0.09 +4.64%
TNFATNF Pharmaceuticals Inc.0.109+0.0028+2.64%-- 
After Hours 0.10015 -0.00885 -8.12%
NCNANuCana plc0.0502--0.000%-- 
After Hours 0.0503 +0.0001 +0.20%
BRNSBarinthus Biotherapeutics plc1.42+0.4+39.22%-- 
After Hours 1.34 -0.08 -5.63%
WINTWindtree Therapeutics Inc.0.9+0.0714+8.62%0.84PE
After Hours 0.8596 -0.0404 -4.49%
Quotes are at least 15-min delayed：2025/07/16 16:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.